The leading Berkeley, California-based, biotechnology company discusses the future of cannabinoids in personal care
This article is sponsored by Demetrix
Demetrix is the leading biotechnology company that is pioneering the study and production of the more than 100 rare cannabinoids and their interactions with the human body.
After launching its commercial manufacturing campaign to support sales of cannabigerol (CBG), the firm has made a number of revelations in the cannabinoid field.
Far from fleeting beauty trend, here Cynthia Bryant, Chief Business Office of Demetrix, reveals the future of CBD and cannbinoids in personal care and which areas are rife for development.
For more interviews with leading companies from across the cosmetics industry, subscribe to our YouTube channel.
'Cosmetics Business in conversation with' is a series of exclusive video interviews with leading companies in the beauty and personal care industry, conducted by our award-winning team of B2B beauty journalists.
This interview was led by Sarah Parsons, Digital Editor at Cosmetics Business. To learn more about the Cosmetics Business team, visit About Cosmetics Business.